Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-04

Clinical Trial Update: AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD) [Phase 3]

View source ↗

Summary

A phase 3 trial comparing Crestor 10 mg to placebo in subjects with end-stage renal disease has completed, with results posted in November 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Renal Failure | Phase 3 | Status: COMPLETED | Results posted: 2009-11-04